Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 6 studies | 24% ± 7% | |
microglial cell | 5 studies | 23% ± 6% | |
endothelial cell | 4 studies | 25% ± 7% | |
astrocyte | 4 studies | 23% ± 5% | |
glutamatergic neuron | 4 studies | 34% ± 11% | |
adipocyte | 3 studies | 21% ± 6% | |
GABAergic neuron | 3 studies | 34% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 7% | |
oligodendrocyte | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1631.31 | 1445 / 1445 | 100% | 18.64 | 183 / 183 |
lung | 100% | 2315.79 | 578 / 578 | 100% | 12.76 | 1154 / 1155 |
breast | 100% | 2270.23 | 459 / 459 | 100% | 17.26 | 1117 / 1118 |
prostate | 100% | 2215.49 | 245 / 245 | 100% | 12.85 | 501 / 502 |
stomach | 100% | 1526.34 | 359 / 359 | 100% | 17.96 | 285 / 286 |
bladder | 100% | 2062.43 | 21 / 21 | 100% | 13.99 | 502 / 504 |
uterus | 100% | 2199.44 | 170 / 170 | 100% | 12.54 | 457 / 459 |
ovary | 100% | 2409.37 | 180 / 180 | 100% | 10.04 | 428 / 430 |
pancreas | 100% | 1309.71 | 328 / 328 | 99% | 14.76 | 177 / 178 |
intestine | 100% | 2144.56 | 966 / 966 | 99% | 18.25 | 524 / 527 |
brain | 99% | 1389.49 | 2621 / 2642 | 100% | 21.29 | 705 / 705 |
thymus | 100% | 2268.16 | 653 / 653 | 99% | 14.56 | 600 / 605 |
kidney | 100% | 1547.93 | 89 / 89 | 98% | 13.34 | 879 / 901 |
adrenal gland | 100% | 1736.07 | 258 / 258 | 96% | 11.42 | 221 / 230 |
skin | 100% | 1649.81 | 1808 / 1809 | 94% | 14.35 | 443 / 472 |
liver | 100% | 1527.77 | 226 / 226 | 90% | 6.46 | 364 / 406 |
adipose | 100% | 2247.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1640.00 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.28 | 29 / 29 |
spleen | 100% | 3554.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.14 | 45 / 45 |
muscle | 100% | 1046.74 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 923.09 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 1094.83 | 811 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 6.97 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009301 | Biological process | snRNA transcription |
GO_0016926 | Biological process | protein desumoylation |
GO_0008283 | Biological process | cell population proliferation |
GO_0030576 | Biological process | Cajal body organization |
GO_0006508 | Biological process | proteolysis |
GO_0015030 | Cellular component | Cajal body |
GO_0005615 | Cellular component | extracellular space |
GO_0032183 | Molecular function | SUMO binding |
GO_0016929 | Molecular function | deSUMOylase activity |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | USPL1 |
Protein name | Alternative protein USPL1 SUMO-specific isopeptidase USPL1 (EC 3.4.22.-) (Ubiquitin-specific peptidase-like protein 1) (USP-like 1) |
Synonyms | D13S106 C13orf22 |
Description | FUNCTION: SUMO-specific isopeptidase involved in protein desumoylation. Specifically binds SUMO proteins with a higher affinity for SUMO2 and SUMO3 which it cleaves more efficiently. Also able to process full-length SUMO proteins to their mature forms . Plays a key role in RNA polymerase-II-mediated snRNA transcription in the Cajal bodies . Is a component of complexes that can bind to U snRNA genes . . |
Accessions | L8ECC7 ENST00000614860.1 [Q5W0Q7-2] Q5W0Q7 ENST00000255304.9 [Q5W0Q7-1] |